Skip to main content
. 2021 Oct 31;2021:2570472. doi: 10.1155/2021/2570472

Table 3.

Results of the pairwise meta-analysis.

Comparison n SBP n DBP n NO n ET
MD (95% CI) MD (95% CI) MD (95% CI) MD (95% CI)
TC + AHD vs AHD 15 12.25 (16.22 to –8.28) 15 –7.58 (–9.98 to –5.19) 3 3.05 (–1.32 to 7.43) 2 –11.94 (–25.29 to 1.41)
BDJ + AHD vs AHD 11 –6.92 (–8.70 to –5.14) 11 –4.50 (–7.08 to –1.92) 3 4.42 (3.26 to 5.58) 4 –9.23 (–10.85 to –7.61)
WQX + AHD vs AHD 3 –4.10 (–9.39 to 1.19) 3 –3.23 (–9.98 to 3.52)

SBP: systolic blood pressure; DBP: diastolic blood pressure; NO: nitric oxide; ET: endothelin; AHD: antihypertensive drugs; TC + AHD: Tai Chi plus antihypertensive drugs; BDJ + AHD: Baduanjin plus antihypertensive drugs; WQX + AHD: Wuqinxi plus antihypertensive drugs; MD: mean difference; and CI: credible intervals. The bold values mean that the results are statistically significant.